What the Ringling Brothers’ retired elephants have to do with cancer research

When it comes to developing cancer, risk increases with body size and life span, according to the National Institutes of Health. This is because the more cells an organism has, and the longer the organism lives, the greater number of cell divisions it will undergo. Elephants, however, have a lower-than-expected rate of cancer, even though the odds are against them. A research project underway in Florida involving retired circus elephants is working to find out why, Slate reports.

Advertisement

Two of the elephants involved in the project, Julia and Sara, are recent retirees of Ringling Brothers and Barnum & Bailey Circus, which have now stopped using elephants in their performances.

The project is led by Joshua D. Schiffman, MD, a pediatric oncologist, and will be housed at the Center for Elephant Conservation in Polk City, Fla., according to Slate.   The research will focus on the blood of elephants, which contains a gene that suppresses tumor growth, in hopes that a synthetic version might be developed. 

More articles on cancer research:

2 Google and Twitter executives create genetic cancer testing startup 
The importance of community hospitals’ participation in clinical research 
With support of investors, better cancer cures are possible 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Rankings and Ratings

Advertisement

Comments are closed.